Immunotherapy is a promising new therapeutic approach in breast cancer, making it crucial to understand how to maximize the benefit based on patient- and disease-specific features. Tune in to this webcast where leading experts in breast cancer discuss guideline-aligned treatment selection and sequencing of immunotherapy based on the latest efficacy and safety data, practical management of adverse events, and opportunities for advancing breast cancer care in federal and public health settings.
- Provider:PRIME Education, Inc. (PRIME®)
- Activity Link: https://primeinc.org/online/targeting-new-era-precision-oncology-treating-solid-tumors-federal-public
- Start Date: 2025-03-14 05:00:00
- End Date: 2025-03-14 05:00:00
- Credit Details: IPCE Credits: 0.5 hours
AAPA Category 1 Credit™️: 0.5 hours
AMA PRA Category 1 Credit™️: 0.5 hours
Nursing: 0.5 hours
Pharmacy: 0.5 hours - MOC Credit Details: ABIM - 0.5 Point; Credit Type(s): Medical Knowledge (ABIM)
- Commercial Support: Source: Aveo Pharmaceuticals - Amount: 2083.33 - Is Kind Support: False Source: Merck (Any division) - Amount: 16666.67 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence, Learner/Team Performance
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Medical Oncology
Subscribe
Login
0 Comments
Oldest